摘要
ARIs for diabetes: A series of 2-(3-benzyl-2-oxoquinoxalin-1(2H)-yl)acetic acid derivatives were designed and synthesized as inhibitors of aldose reductase (AR), a novel target for the treatment of diabetes complications. Most of the derivatives proved to be potent and selective, with IC50 values in the low nanomolar to micromolar range.
源语言 | 英语 |
---|---|
页(从-至) | 1913-1917 |
页数 | 5 |
期刊 | ChemMedChem |
卷 | 8 |
期 | 12 |
DOI | |
出版状态 | 已出版 - 12月 2013 |
指纹
探究 'Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors' 的科研主题。它们共同构成独一无二的指纹。引用此
Wu, B., Yang, Y., Qin, X., Zhang, S., Jing, C., Zhu, C., & Ma, B. (2013). Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors. ChemMedChem, 8(12), 1913-1917. https://doi.org/10.1002/cmdc.201300324